Wells Fargo & Company MN Raises Stock Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Wells Fargo & Company MN boosted its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 0.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 253,182 shares of the company’s stock after acquiring an additional 1,210 shares during the period. Wells Fargo & Company MN’s holdings in Crescent Capital BDC were worth $4,866,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of CCAP. Raymond James Financial Inc. purchased a new stake in Crescent Capital BDC in the fourth quarter valued at about $3,750,000. Franklin Resources Inc. grew its stake in shares of Crescent Capital BDC by 35.2% during the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after acquiring an additional 66,713 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Crescent Capital BDC during the fourth quarter valued at about $661,000. Redhawk Wealth Advisors Inc. purchased a new position in shares of Crescent Capital BDC in the 4th quarter valued at approximately $659,000. Finally, Stifel Financial Corp boosted its stake in Crescent Capital BDC by 53.1% in the 3rd quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock worth $1,230,000 after purchasing an additional 23,055 shares in the last quarter. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Keefe, Bruyette & Woods cut their price target on shares of Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating on the stock in a research note on Tuesday, April 8th. Wells Fargo & Company dropped their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $18.90.

Crescent Capital BDC Price Performance

Shares of NASDAQ CCAP opened at $15.48 on Monday. Crescent Capital BDC, Inc. has a 52 week low of $13.54 and a 52 week high of $20.19. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The firm has a market cap of $573.76 million, a P/E ratio of 7.78 and a beta of 0.56. The business’s 50 day moving average price is $17.22 and its 200 day moving average price is $18.41.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The business had revenue of $46.40 million during the quarter, compared to analysts’ expectations of $47.27 million. On average, sell-side analysts expect that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Dividend Announcement

The business also recently declared a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC’s dividend payout ratio is currently 84.42%.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.